CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals...
Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid,...
GLEN ALLEN, Va., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
SALT LAKE CITY, UT / ACCESSWIRE / August 13, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first...
$2.1M invested in seven companies to advance innovations from lab to market in Maryland COLUMBIA, Md., Aug. 13, 2024 /PRNewswire/...
Compassion Center, headquartered in Hillsboro, Oregon, is a pioneer in integrative healthcare, dedicated to improving global quality of life through...
Leading Neuroscientists, Technologists, Regulators, and Venture Capitalists Convening in West Virginia MORGANTOWN, W.Va., Aug. 9, 2024 /PRNewswire/ -- West Virginia...
Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
New solution to improve patient treatment unveiled at the United States Association of Opioid Treatment Providers (USAOTP) Annual Conference AUSTIN,...
ASHBURN, Va., Aug. 7, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Unregulated...
Patient dosing has concluded for the second and last cohort of the pharmacokinetics study of AD04 Topline results expected during...
Partnership delivers innovative reimbursement options for S.T. Genesis, a medical device indicated for opioid withdrawal symptom managementBOCA RATON, Fla., Aug....
NEW YORK and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
STOCKHOLM, SE / ACCESSWIRE / August 07, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
- Holistic approach to measurement provides meaningful real-world impact evaluation - CLEVELAND, Aug. 06, 2024 (GLOBE NEWSWIRE) -- A new...
Tampa, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Turning Point of Tampa is proud to announce that Dr. Hardeep Singh,...
SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by combining SciSparc’s Palmitoylethanolamide...
Generated Robust 28% Year-over-Year Revenue Growth in Q2 2024 Recorded Positive Quarterly Net Income for Third Consecutive Quarter, and Positive...
In 2022 breast cancer was the most common cancer in women in 157 countries out of 185, and lung cancer...
Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...